KR960702000A - 귀밑샘염 바이러스로부터의 재조합 항원 및 백신에서의 이것의 사용방법(recombinant antigens from mumps virus and their use in vaccines) - Google Patents
귀밑샘염 바이러스로부터의 재조합 항원 및 백신에서의 이것의 사용방법(recombinant antigens from mumps virus and their use in vaccines)Info
- Publication number
- KR960702000A KR960702000A KR1019950704819A KR19950704819A KR960702000A KR 960702000 A KR960702000 A KR 960702000A KR 1019950704819 A KR1019950704819 A KR 1019950704819A KR 19950704819 A KR19950704819 A KR 19950704819A KR 960702000 A KR960702000 A KR 960702000A
- Authority
- KR
- South Korea
- Prior art keywords
- vector
- protein
- denoted
- fusion
- derived
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title claims 3
- 239000000427 antigen Substances 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 241000711386 Mumps virus Species 0.000 title 1
- 239000012528 membrane Substances 0.000 claims abstract 11
- 108090000623 proteins and genes Proteins 0.000 claims abstract 11
- 102000004169 proteins and genes Human genes 0.000 claims abstract 11
- 102000037865 fusion proteins Human genes 0.000 claims abstract 9
- 108020001507 fusion proteins Proteins 0.000 claims abstract 9
- 238000004873 anchoring Methods 0.000 claims abstract 8
- 108090001074 Nucleocapsid Proteins Proteins 0.000 claims abstract 7
- 108091008324 binding proteins Proteins 0.000 claims abstract 6
- 108020004414 DNA Proteins 0.000 claims abstract 5
- 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 claims abstract 3
- 101710133291 Hemagglutinin-neuraminidase Proteins 0.000 claims abstract 3
- 230000001580 bacterial effect Effects 0.000 claims abstract 3
- 210000004027 cell Anatomy 0.000 claims abstract 3
- 230000004927 fusion Effects 0.000 claims abstract 3
- 210000004962 mammalian cell Anatomy 0.000 claims abstract 3
- 206010034038 Parotitis Diseases 0.000 claims abstract 2
- 108010076504 Protein Sorting Signals Proteins 0.000 claims abstract 2
- 108020004511 Recombinant DNA Proteins 0.000 claims abstract 2
- 241000700618 Vaccinia virus Species 0.000 claims abstract 2
- 102000023732 binding proteins Human genes 0.000 claims 5
- 238000000034 method Methods 0.000 claims 4
- 230000002950 deficient Effects 0.000 claims 3
- 230000001131 transforming effect Effects 0.000 claims 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims 1
- 206010046865 Vaccinia virus infection Diseases 0.000 claims 1
- 238000003776 cleavage reaction Methods 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 102000005396 glutamine synthetase Human genes 0.000 claims 1
- 108020002326 glutamine synthetase Proteins 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000007017 scission Effects 0.000 claims 1
- 238000010561 standard procedure Methods 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 208000007089 vaccinia Diseases 0.000 claims 1
- 102000014914 Carrier Proteins Human genes 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 description 6
- 238000010586 diagram Methods 0.000 description 5
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/033—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
- C12N2760/18722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939308963A GB9308963D0 (en) | 1993-04-30 | 1993-04-30 | Novel compounds |
| GB9308963.9 | 1993-04-30 | ||
| PCT/EP1994/001297 WO1994025600A1 (en) | 1993-04-30 | 1994-04-26 | Recombinant antigens from mumps virus and their use in vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR960702000A true KR960702000A (ko) | 1996-03-28 |
Family
ID=10734747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019950704819A KR960702000A (ko) | 1993-04-30 | 1994-04-26 | 귀밑샘염 바이러스로부터의 재조합 항원 및 백신에서의 이것의 사용방법(recombinant antigens from mumps virus and their use in vaccines) |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0695358A1 (zh) |
| JP (1) | JPH08512199A (zh) |
| KR (1) | KR960702000A (zh) |
| CN (1) | CN1126492A (zh) |
| AU (1) | AU6964894A (zh) |
| CA (1) | CA2161645A1 (zh) |
| GB (1) | GB9308963D0 (zh) |
| WO (1) | WO1994025600A1 (zh) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6100064A (en) * | 1984-04-06 | 2000-08-08 | Chiron Corporation | Secreted viral proteins useful for vaccines and diagnostics |
| JP4422804B2 (ja) | 1997-03-11 | 2010-02-24 | メイヨー・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ | 望ましくない細胞を排除するための組成物および方法 |
| EP0988052A2 (en) * | 1997-05-23 | 2000-03-29 | SCHWEIZ. SERUM- & IMPFINSTITUT BERN | An influenza enveloped dna vaccine |
| WO2000018929A2 (en) * | 1998-09-25 | 2000-04-06 | Smithkline Beecham Biologicals S.A. | Paramyxovirus vaccines |
| CN1843507B (zh) * | 2006-02-14 | 2010-04-21 | 中国医学科学院医学生物学研究所 | 一种人用腮腺炎病毒组份疫苗及其制备方法和应用 |
| CN106290862B (zh) * | 2016-08-05 | 2017-10-31 | 北京市华信行生物科技有限公司 | 腮腺炎病毒hn抗原及其在检测抗腮腺炎病毒抗体中的用途 |
| US20230053555A1 (en) * | 2019-12-11 | 2023-02-23 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic | Mumps and measles virus immunogens and their use |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989011534A1 (en) * | 1988-05-24 | 1989-11-30 | Board Of Regents, The University Of Texas System | Mumps virus hemagglutinin-neuraminidase |
-
1993
- 1993-04-30 GB GB939308963A patent/GB9308963D0/en active Pending
-
1994
- 1994-04-26 WO PCT/EP1994/001297 patent/WO1994025600A1/en not_active Application Discontinuation
- 1994-04-26 AU AU69648/94A patent/AU6964894A/en not_active Abandoned
- 1994-04-26 JP JP6523863A patent/JPH08512199A/ja active Pending
- 1994-04-26 CA CA002161645A patent/CA2161645A1/en not_active Abandoned
- 1994-04-26 CN CN94192620.6A patent/CN1126492A/zh active Pending
- 1994-04-26 KR KR1019950704819A patent/KR960702000A/ko not_active Application Discontinuation
- 1994-04-26 EP EP94915539A patent/EP0695358A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| GB9308963D0 (en) | 1993-06-16 |
| EP0695358A1 (en) | 1996-02-07 |
| CN1126492A (zh) | 1996-07-10 |
| JPH08512199A (ja) | 1996-12-24 |
| CA2161645A1 (en) | 1994-11-10 |
| AU6964894A (en) | 1994-11-21 |
| WO1994025600A1 (en) | 1994-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR960022559A (ko) | 슈도모나스 에루지노사 막 단백질로부터 유도된 면역원성 하이브리드 단백질 OprF-Oprl | |
| NZ514528A (en) | Vectors comprising the sequnece for a respiratory syncytial virus (RSV) F protein with a heterologous signal sequence (HSV I gD) for vaccines | |
| AU585512B2 (en) | Antigenic proteins and vaccines containing them and protective antibodies directed to them for prevention of coccidiosis caused by eimeria tenella and eimeria necatrix | |
| AU4826493A (en) | Anti-feline immunodeficiency virus (fiv) vaccines | |
| ATE298798T1 (de) | Fusionsproteine zwischen antigene aminosäuresequenzen und beta - 2- mikroglobulin | |
| KR960702000A (ko) | 귀밑샘염 바이러스로부터의 재조합 항원 및 백신에서의 이것의 사용방법(recombinant antigens from mumps virus and their use in vaccines) | |
| ATE262539T1 (de) | Immunoreaktive peptid ctl epitope von menschlichem cytomegalovirus | |
| EP0294469A4 (en) | VACCINES AND DIAGNOSTIC ANALYSIS FOR HAEMOPHILUS INFLUENZAE. | |
| ATE123525T1 (de) | Fusionsproteine der untereinheit b von choleratoxin und eines heterologen antigens und dafür kodierende rekombinante nukleinsäure. | |
| KR970703428A (ko) | Hcmv 및 hsv로부터의 융합 당단백질(fusion glycoprotein from hcmv and hsv) | |
| WO1995019371A3 (en) | Expression of surface layer proteins | |
| KR930702522A (ko) | 인체의 투명층 단백질 제트피 3 (zp3) | |
| AU3379693A (en) | Vaccines and diagnostic assays for haemophilus influenzae | |
| EP1512693A3 (en) | Novel polypeptide, DNA coding for said polypeptide, recombinant vector containing said DNA, recombinant virus prepared using said vector, and use thereof | |
| Gauss‐Müller et al. | Recombinant proteins VP1 and VP3 of hepatitis A virus prime for neutralizing response | |
| WO1993014206A3 (en) | Synthetic peptides for a rubella vaccine | |
| DE69836647D1 (de) | Methode zur herstellung von (poly)peptiden unter verwendung von verkürzten varianten von sv40 'large' t antigen mit einem intakten n terminus | |
| DE3884672D1 (de) | Ein synthetisches Nonapeptid zur Verwendung als Adjuvant. | |
| ES2074965A1 (es) | Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen. | |
| ES8801127A1 (es) | Un procedimiento para preparar una vacuna auto antigena en forma de virus modificado de la viruela vacuna. | |
| Dietzschold et al. | Synthesis of an antigenic determinant of the HSV gD that stimulates the induction of virus-neutralizing antibodies and confers protection against a lethal challenge of HSV. | |
| KR950704494A (ko) | 수두-대상포진 바이러스(vzv)에 대한 백신(vaccines against varicellazoster virus(vzv)) | |
| Zuckerman | Immunization Against Hepatitis B | |
| AR036104A1 (es) | Un receptor acoplado a la proteina g, gave3 | |
| Znt | Patent Report |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |